EUVIMEDEUVIMED entdecken
Open Access

Feasibility and Safety of Repeat Robot‐Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series

Nao Yukimatsu iD, Takeshi Yamasaki, Taisuke Matsue, Shoma Yamamoto iD, Taiyo Otoshi, Minoru Kato, Junji Uchida

International Journal of Urology · 2026

DOI: 10.1111/iju.70581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Nao Yukimatsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. Hauptthemen laut MEDLINE: Nephrectomy, Kidney Neoplasms, Carcinoma, Renal Cell, Robotic Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the feasibility, safety, and short‐term oncological and functional outcomes of repeat robot‐assisted partial nephrectomy (RAPN) for ipsilateral local recurrence of renal cell carcinoma after partial nephrectomy (PN) and describe the relevant surgical strategies.

Methods

We retrospectively evaluated eight consecutive patients who underwent repeat RAPN between April 2019 and January 2026. Patient characteristics, perioperative outcomes, renal function, pathological findings, and adhesion severity were analyzed. Intraoperative adhesions were graded as minor or severe based on the surgeon's assessment.

Results

Eleven ipsilateral recurrent tumors were analyzed in eight patients. Repeat RAPN was successfully performed in all patients without conversion to open surgery or radical nephrectomy. The median operative time, warm ischemia time, and estimated blood loss were 157 min, 15 min, and 50 mL, respectively. No major (Clavien–Dindo grade ≥ III) complications occurred. All malignant tumors were pT1a with negative surgical margins. At the median follow‐up of 17.5 months, no local recurrence or distant metastasis was observed. The median eGFR values at 1 and 3 months were 57.1 and 55.7 mL/min/1.73 m 2 , respectively. Severe adhesions were more common among patients who did not receive anti‐adhesion agents during initial surgery.

Conclusions

Repeat RAPN may be a feasible and safe salvage option for ipsilateral recurrence after PN, with acceptable early oncological and functional outcomes. Our findings suggest that anti‐adhesion agent use during the initial PN may be associated with reduced adhesion‐related difficulty during subsequent reoperations, although further validation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrectomyKidney NeoplasmsCarcinoma, Renal CellRobotic Surgical ProceduresNeoplasm Recurrence, LocalReoperationHumansFemaleMaleRetrospective StudiesFeasibility StudiesMiddle AgedAgedTissue AdhesionsTreatment OutcomeOperative Time

Stichwörter der Autor:innen

local recurrencepartial nephrectomyrenal cell carcinomareoperationrobotic surgical procedures

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

ORCID-Profile: Nao Yukimatsu, Shoma Yamamoto

Zitieren

APA

Yukimatsu, N., Yamasaki, T., Matsue, T., Yamamoto, S., Otoshi, T., Kato, M., & Uchida, J. (2026). Feasibility and Safety of Repeat Robot‐Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series. International Journal of Urology. https://doi.org/10.1111/iju.70581

Vancouver

Yukimatsu N, Yamasaki T, Matsue T, Yamamoto S, Otoshi T, Kato M, et al. Feasibility and Safety of Repeat Robot‐Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series. International Journal of Urology. 2026. doi:10.1111/iju.70581

BibTeX
@article{Yukimatsu2026,
  author = {Yukimatsu, Nao and Yamasaki, Takeshi and Matsue, Taisuke and Yamamoto, Shoma and Otoshi, Taiyo and Kato, Minoru and Uchida, Junji},
  title = {Feasibility and Safety of Repeat Robot‐Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70581}
}
Kostenlos starten →